Pfizer Unit, EPA Reach $2.2M Deal Over CAA Violations
The consent decree, filed concurrently with the complaint, calls for King Pharmaceuticals LLC to make equal payments of $1.1 million to the EPA and to the Tennessee Department of Environment and Conservation. The settlement also requires the Bristol, Tenn., pharmaceutical facility to become compliant with national emissions standards.
The emissions standards,...
To view the full article, register now.